SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PolyMedix
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tnsaf9/7/2011 9:32:49 PM
   of 77
 
PolyMedix to Present at the Rodman and Renshaw Global Investment Conference

RADNOR, Pa., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and life-threatening infectious diseases, will be presenting at the Rodman & Renshaw Global Investment Conference. The Conference will take place September 12-13, 2011 at the Waldorf-Astoria in New York, NY.

Nicholas Landekic, President & CEO of PolyMedix will present on Monday, September 12, 2011 at 11:15 AM ET. The presentation will be webcast live and may be accessed at wsw.com or on the Company's website at www.polymedix.com. A replay will be available for 90 days following the event.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News